CD161 is a potent, selective, and orally bioavailable BET bromodomain inhibitor (IC50s: 28.2 nM and 7.2 nM for BRD4 BD1 and BRD4 BD2) with good anticancer activity.
Molecular Weight:
435.48
CAS Number:
[1627716-22-6]
Formula:
C26H21N5O2
Target:
Others|||Epigenetic Reader Domain
T14910
* VAT and and shipping costs not included. Errors and price changes excepted